首页> 外文期刊>The heart surgery forum >TandemHeart device as rescue therapy in the management of acute heart failure
【24h】

TandemHeart device as rescue therapy in the management of acute heart failure

机译:TandemHeart设备作为急诊心力衰竭治疗中的抢救疗法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: The TandemHeart device (THD) is a pump system that can be deployed percutaneously (PC) or via conventional surgical (CS) cannulation; it is capable of supporting one or both ventricles. It is a versatile system designed for use as a rescue device in acute heart failure and as a bridge to decision in moribund patients. Methods: Retrospective analysis was conducted on all patients who underwent a THD implant; either PC or CS; at our institution. Univariate analysis was done using Fisher's exact and Chi-square tests for categorical variables and Wilcoxon Rank Sum test for continuous ones. Results: 51 adult patients were identified: 10 PC and 41 CS. Mean age was 58.9 ± 12.8 years, and 31% were female. In hospital mortality was 61%. Univariate predictors of death were prolonged support (74% versus 46%, P = .04) and higher lactic acid levels (5.3 ± 4.9 versus 2.3 ± 1.9 mmol/L, P = .012). The length of stay (LOS) for survivors was 59.8 ± 30.0 days. Conclusion: Uni- or bi-ventricular unloading can be successfully achieved using the THD, either trans-thoracically or percutaneously, with an acceptable complication profile.
机译:背景:TandemHeart设备(THD)是一种泵系统,可以经皮(PC)或通过常规外科手术(CS)插管进行部署。它能够支撑一个或两个心室。它是一种多功能系统,旨在用作急性心力衰竭的急救设备,以及为垂死患者提供决策的桥梁。方法:对所有接受THD植入的患者进行回顾性分析。 PC或CS;在我们的机构。使用Fisher精确检验和卡方检验(用于分类变量)和Wilcoxon Rank Sum检验(用于连续变量)进行单变量分析。结果:确定了51名成年患者:10例PC和41例CS。平均年龄为58.9±12.8岁,女性为31%。在医院死亡率为61%。死亡的单因素预测因素是支持时间延长(74%对46%,P = .04)和较高的乳酸水平(5.3±4.9对2.3±1.9 mmol / L,P = .012)。幸存者的住院天数(LOS)为59.8±30.0天。结论:THD可经胸或经皮成功完成单心室或双心室卸载,并具有可接受的并发症特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号